These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37368028)

  • 1. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
    Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells.
    Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M
    Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
    Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
    AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study.
    Honarvari B; Karimifard S; Akhtari N; Mehrarya M; Moghaddam ZS; Ansari MJ; Jalil AT; Matencio A; Trotta F; Yeganeh FE; Farasati Far B; Arki MK; Naimi-Jamal MR; Noorbazargan H; Lalami ZA; Chiani M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Gingerol-loaded Uio-66 nanoparticles and its anti-cancer effect against gastric cancer cell line (AGS).
    Kazazi I; Ashrafi F; Malekloo M
    Mol Biol Rep; 2023 Apr; 50(4):3503-3513. PubMed ID: 36787050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
    Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
    Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells.
    Ahmadi SM; Seyedabadi M; Ebrahimnejad P; Abasi M; Nokhodchi A
    AAPS PharmSciTech; 2024 Sep; 25(7):213. PubMed ID: 39266895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic Acid-Decorated pH-Responsive Nanoniosomes With Enhanced Endocytosis for Breast Cancer Therapy:
    Rezaei T; Rezaei M; Karimifard S; Mahmoudi Beram F; Dakkali MS; Heydari M; Afshari-Behbahanizadeh S; Mostafavi E; Bokov DO; Ansari MJ; Farasati Far B; Akbarzadeh I; Chaiyasut C
    Front Pharmacol; 2022; 13():851242. PubMed ID: 35517801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation.
    Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
    Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-gingerol encapsulated niosomal formulation against carbapenem-resistant
    Karbalaeiheidar H; Ashrafi F
    Biomed Mater; 2023 May; 18(4):. PubMed ID: 37187182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy.
    Khodabakhsh F; Bourbour M; Yaraki MT; Bazzazan S; Bakhshandeh H; Ahangari Cohan R; Tan YN
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
    Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
    Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer.
    Moammeri A; Abbaspour K; Zafarian A; Jamshidifar E; Motasadizadeh H; Dabbagh Moghaddam F; Salehi Z; Makvandi P; Dinarvand R
    ACS Appl Bio Mater; 2022 Feb; 5(2):675-690. PubMed ID: 35129960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.
    He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD
    J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells.
    Alali U; Mohammed Kadhim Al-Tu'ma M; Fadhil Jawad A; Talib Ahmed S; Addai Ali H; Abdulzehra S; Jawad Al-Tu'ma F
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2539-2550. PubMed ID: 39068589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.